Subhashis Banerjee sold $12k of ARTV
Chief Medical Officer at Artiva Biotherapeutics, Inc.. 1,100 shares at an average of $11.16, traded Sep 3, 2026, filed Sep 4, 2026.
Score components
- +15RoleOfficer
- 0Trade size$12k at market
- 0Share of holdings soldSold 0.8% of holdings
- +15Cluster4 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-383619, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | SOpen-market sale Common Stock | -1,100 | $11.16 | $12k | 140,947 | 38 d ago |
Related signals
Other insiders at Artiva Biotherapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | Artiva Biotherapeutics, Inc. | Fred Aslan Chief Executive Officer | $169k 23,463 shares | -2% | |
| 56Moderate | Artiva Biotherapeutics, Inc. | Fred Aslan Chief Executive Officer | $422k 61,696 shares | -4% | |
| 30Weak | Artiva Biotherapeutics, Inc. | Subhashis Banerjee Chief Medical Officer | $7,514 1,099 shares | -1% | |
| 42Moderate | Artiva Biotherapeutics, Inc. | Jennifer Bush COO, CLO, Compliance Officer | $57k 8,370 shares | -2% | |
| 38Weak | Artiva Biotherapeutics, Inc. | Christopher Horan Chief Tech Operations Officer | $71k 10,340 shares | -3% | |
| 33Weak | Artiva Biotherapeutics, Inc. | Fred Aslan Chief Executive Officer | $256k 23,429 shares | -2% | |
| 61Notable | Artiva Biotherapeutics, Inc. | Fred Aslan Chief Executive Officer | $690k 61,888 shares | -4% | |
| 45Moderate | Artiva Biotherapeutics, Inc. | Jennifer Bush COO, CLO, Compliance Officer | $94k 8,391 shares | -2% | |
| 40Moderate | Artiva Biotherapeutics, Inc. | Christopher Horan Chief Tech Operations Officer | $116k 10,366 shares | -4% | |
| 13Weak | Artiva Biotherapeutics, Inc. | Fred Aslan President and CEO | $70k 25,500 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.